ROLE OF IRF5 IN SLE PATHOGENESIS

描述(申请人提供)：这项建议的主要目标是表征干扰素(干扰素)调节因子-5(IRF-5)转录因子在系统性红斑狼疮(SLE)发病机制中的生理作用。SLE是一种慢性系统性自身免疫性疾病，影响约0.1%的美国人口，并导致一系列器官系统的炎症和损害。虽然SLE的主要原因尚未确定，但病毒感染或免疫系统功能障碍已被提出。一些证据表明，先天免疫反应与系统性红斑狼疮的发病机制有关。浆细胞样树突状细胞(PDC)是天然免疫反应的关键介质，特别是通过其分泌细胞因子的能力。它们也是I型干扰素的主要来源，I型干扰素是一种在对抗病毒感染的第一线防御中至关重要的分子，最近的数据表明，PDCs产生的干扰素可能在SLE的发病机制中起重要作用。I型干扰素在启动进一步产生干扰素的能力方面是显著的，这可能通过干扰素调节因子发生，如IRF-3、IRF-5和IRF-7。最近的数据表明，IRF-5基因的多态性与SLE有关，在与SLE的连锁和关联的联合分析中，发现了单核苷酸多态(SNPs)。IRF-5主要在免疫系统的细胞，特别是PDC、单核细胞、单核细胞来源的树突状细胞以及B细胞中表达。随着最近发现了多种选择性剪接的IRF-5亚型，每个亚型都有不同的细胞类型特异性表达、调节和功能，有理由认为IRF-5内的多态性可能会影响一些对自身免疫性疾病(如SLE)的发展至关重要的细胞功能。因此，我们假设IRF-5亚型表达和功能的改变在SLE患者血清中I型IFN水平升高的SLE发病机制中起重要作用。为了验证这一假说，1)研究了与SLE发病相关的IRF-5亚型表达的特征，2)确定了与SLE相关的IRF-5基因多态性的生理意义。这些研究结果将为我们理解IRF-5在SLE自身免疫和病理现象中的生理作用提供新的视角。

DESCRIPTION (provided by applicant): The primary goal of this proposal is to characterize the physiological role of the interferon (IFN) regulatory factor-5 (IRF-5) transcription factor in the pathogenesis of systemic lupus erythematosus (SLE). SLE is a chronic systemic autoimmune disease that affects about 0.1% of the US population, and results in inflammation and damage to a range of organ systems. While the primary cause of SLE has not been determined, viral infection or dysfunction of the immune system has been suggested. Several lines of evidence have linked innate immune responses with the pathogenesis of SLE. Plasmacytoid dendritic cells (PDCs) are key mediators of innate immune responses, particularly via their ability to secrete cytokines. They are also the primary source of type I IFN, a molecule important in the front-line defense against viral infection, and recent data suggest that IFN produced by PDCs might be important for SLE pathogenesis. Type I IFNs are remarkable in their ability to prime further IFN production, which is likely to occur through the IFN regulatory factors, such as IRF-3, IRF-5, and IRF-7. Recent data indicate that polymorphism within the IRF-5 gene is associated with SLE; single-nucleotide polymorphisms (SNPs) were identified in the IRF-5 gene that displayed strong signals in joint analysis of linkage and association with SLE. IRF-5 is constitutively expressed mainly in cells of the immune system, particularly in PDC, monocytes, monocytederived dendritic cells, as well as in B cells. With the recent identification of multiple alternatively spliced IRF- 5 isoforms, each with distinct cell type-specific expression, regulation, and function, it is reasonable to suggest that polymorphism within IRF-5 may affect several cellular functions of importance for the development of an autoimmune disease such as SLE. As such, we hypothesize that alterations in IRF-5 isoform expression and function play an important role in SLE pathogenesis associated with the elevated levels of type I IFNs in the serum of SLE patients. The following specific aims have been designed to test this hypothesis, 1) Characterization of IRF-5 isoform expression associated with the pathogenesis of SLE, and 2) Determination of the physiological significance of IRF-5 polymorphism associated with SLE. Results from these studies will provide new insight into our understanding the physiological role for IRF-5 in the autoimmune and pathological phenomena of SLE.